NESPO Trademark

Trademark Overview

On Thursday, June 25, 2015, a trademark application was filed for NESPO with the United States Patent and Trademark Office. The USPTO has given the NESPO trademark a serial number of 86674789. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 11, 2019. This trademark is owned by Amgen Inc.. The NESPO trademark is filed in the Pharmaceutical Products category with the following description:

Prescription pharmaceutical products for stimulating red blood cell production and/or erythropoiesis stimulating protein
nespo

General Information

Serial Number86674789
Word MarkNESPO
Filing DateThursday, June 25, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 11, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2015

Trademark Statements

Goods and ServicesPrescription pharmaceutical products for stimulating red blood cell production and/or erythropoiesis stimulating protein

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 2, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Monday, February 11, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 11, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 2, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 2, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 11, 2018EXTENSION 5 GRANTED
Wednesday, May 9, 2018EXTENSION 5 FILED
Wednesday, May 9, 2018TEAS EXTENSION RECEIVED
Tuesday, December 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 15, 2017EXTENSION 4 GRANTED
Friday, December 15, 2017EXTENSION 4 FILED
Friday, December 15, 2017TEAS EXTENSION RECEIVED
Saturday, May 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 26, 2017EXTENSION 3 GRANTED
Thursday, May 4, 2017EXTENSION 3 FILED
Thursday, May 4, 2017TEAS EXTENSION RECEIVED
Friday, January 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 12, 2017EXTENSION 2 GRANTED
Tuesday, January 3, 2017EXTENSION 2 FILED
Thursday, January 12, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 3, 2017TEAS EXTENSION RECEIVED
Friday, June 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 15, 2016EXTENSION 1 GRANTED
Wednesday, June 15, 2016EXTENSION 1 FILED
Wednesday, June 15, 2016TEAS EXTENSION RECEIVED
Tuesday, January 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 28, 2015ASSIGNED TO EXAMINER
Thursday, July 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 29, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

nespo stimulating production erythropoiesis protein cell blood pharmaceutical products prescription